Health Economics Health Services Research Health Technology Assessment
My research informs decision making in government and health organizations. I am interested in economic evaluations of health services, technologies, programs and policies, including impact evaluation, cost-effectiveness analysis and cost-benefit or return on investment analysis, using both real-world evidence and modelling technique. Recently, I have been researching cost-effectiveness and return on investment of Enhanced Recovery After Surgery, National Surgical Quality Improvement Program, Lung cancer screening, Endovascular therapy, Diabetic Foot Care Clinical Pathway, and Primary Health Care Integrated Geriatric Services Initiative, as well as Economic burden of chronic pain and Impacts of Covid-19 public health measures on ED, hospital, and ICU admissions.
PhD, Umea International School of Public Health, Umea University, Sweden, 2005
MPH, Umea International School of Public Health, Umea University, Sweden, 2001
MD, Hanoi Medical University, Vietnam, 1996